Trial Profile
Prescription Event Monitoring of Doripenem Therapy in Management of Serious Infections
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 07 Oct 2015
Price :
$35
*
At a glance
- Drugs Doripenem (Primary)
- Indications Bacterial infections
- Focus Therapeutic Use
- Sponsors Ranbaxy Laboratories
- 07 Oct 2015 New trial record
- 26 Aug 2015 Results presented at the 31st International Conference on Pharmacoepidemiology and Therapeutic Risk Management.